COVID-19 Supplement #3 Moderna Trial
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
20202022Known Financial Commitments (USD)
$11,154,495Funder
National Institutes of Health (NIH)Principal Investigator
PendingResearch Location
United States of AmericaLead Research Institution
SAINT LOUIS UNIVERSITYResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
6z
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
Saint Louis University (SLU) seeks to expand its service to the Vaccine and TreatmentEvaluation Unit (VTEU) network providing resources and expertise to help the network achieveits objectives of evaluating vaccines, preventive biologics, therapeutics and diagnostics forCOVID-19.